Clinical Trials Browser

INDUSTRY × Has results × HM781-36B × Clear all

NCT02659514 2022-03-11

Study of Poziotinib in Participants With HER2-Positive Metastatic Breast Cancer

Phase 2 Completed

67 enrolled 16 charts

Breast Neoplasms